Treatment of mitochondrial disorders: Practical and theoretical issues

European Journal of Paediatric Neurology

Volumn 3, Issue 5, 1999, Pages 201-208

  Bindoff, Laurence ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Mitochondrial disorders; Mitochondrial respiratory chain dysfunction

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DICHLOROACETIC ACID; RETINOL; RIBOFLAVIN; THIAMINE; UBIQUINONE;

ANTIOXIDANT ACTIVITY; DISEASE CLASSIFICATION; GENE THERAPY; HUMAN; MELAS SYNDROME; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

EID: 0032834033     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(99)90082-X     Document Type: Review

References (36)

1. Jackson MJ, Schaefer J, Johnson MA et al. Presentation and clinical investigation of mitochondrial respiratory chain disease: a study of 51 patients. Brain 1995; 118: 339-357.
2. Shoffner JM. Maternal inheritance and evaluation of oxidative phosphorylation diseases. Lancet 1996; 348: 1283-88.
3. Tulinius MR, Holme E, Kristiansson B et al. Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphological investigations. J Pediatr 1991; 119: 242-250.
4. Tulinius MR, Holme E, Kristiansson B et al. Mitochondrial encephalomyopathies in childhood. II. Clinical maifestations and syndromes. J Pediatr 1991; 119: 251-59.
5. Bindoff LA, Turnbull DM. Defects of the respiratory chain. In: Harris JB, Turnbull DM (eds) Clinical Endocrinology and Metabolism. London: Baillière Tindall, 1990: 583-619.
6. Schatz G, Haslbrunner E, Tuppy H. Deoxyribonucleic acid associated with yeast mitochondria. Biochem Biophys Res Commun 1964; 15: 127-132.
7. Zeviani M, Fernandez-Silva P, Tiranti V. Disorders of mitochondria and related metabolism. Curr Opin Neurol 1997; 10: 160-167.
8. Hartl F-U, Pfanner N, Nicholson DW, Neupert W. Mitochondrial protein import. Biochim Biophys Acta 1989; 988: 1-45.
9. Attardi G, Schatz G. Biogenesis of mitochondria. Ann Rev Cell Biol 1988; 4: 289-333.
10. Wallace DC. Maternal genes: mitochondrial diseases. Birth Defects 1987; 23: 137-190.
11. Lightowlers R, Chinnery P, Turnbull D, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997; 13: 450-455.
12. Suomalainen A, Kaukonen J, Amati P et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet 1995; 9: 146-151.
13. Zeviani M, Petruzzella V, Carrozzo R. Disorders of nuclear-mitochondrial intergenomic signalling. J Bioenerg Biomemb 1997; 29: 121-130.
14. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-692.
15. Zhu Z, Yao J, Johns T et al. SURF-1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet 1998; 20: 337-343.
16. Tiranti V, Hoertnagel K, Carrozzo R et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998; 63: 1609-1621.
17. Loeffen J, Smeitink J, Triepels R et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998; 63: 1598-1608.
18. Prezant TR, Agapian JV, Bohlman MC et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet 1993; 4: 289-294.
19. Taivassalo T, Mathews PM, De Stefano N, et al. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology 1996; 47: 529-534.
20. Mathews PM, Ford B, Dandurand RJ et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993; 43: 884-590.
21. Bindoff LA, Desnuelle C, Birch-Machin MA et al. Multiple defects of the mitochondrial respiratory chain in a mitochondrial encephalopathy (MERRF): a clinical, biochemical and molecular study. J Neurol Sci 1991; 102: 17-24.
22. Wijburg FA, Barth PG, Bindoff LA et al. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics 1992; 23: 147-152.
23. Zeviani M, Peterson P, Servidei S et al. Benign reversible muscle cytochrome c oxidase deficiency: a second case. Neurology 1987; 37: 64-67.
24. Stacpoole PW, A.C.L, Thomas RG, Harman EM. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 1988; 108: 58-63.
25. Saijo T, Naito E, Ito M et al. Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 1991; 22: 166-167.
26. Beal M. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998; 10: 211-223.
27. Watmough NJ, Bindoff LA, Birch-Machin MA et al. Impaired mitochondrial β-oxidation in a patient with an abnormality of the respiratory chain. J Clin Invest 1990; 85: 177-184.
28. Ogasahara S, Enge AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989; 86: 2379-2382.
29. Sutherland L, Davidson J, Jacobs HT. Nuclear expression of mitochondrial genes implicated in human encephalomyopathies. Biochem Soc Trans 1994; 22: 413S.
30. Seibel P, Trappe J, Villani G et al. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucl Acids Res 1995; 23: 10-17.
31. Taylor RT, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genet 1997; 15: 212-215.
32. Weber K, Wilson JN, Taylor L et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet 1997; 60: 373-380.
33. Fu K, Hartlen R, Johns T et al. A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 1996; 5: 1835-1840.
34. Clark K, Bindoff L, Lightowlers R et al. Correction of a mitochondrial DNA defect in human skeletal muscle. Nature Genet 1997; 16: 222-224.
35. Rubenstein DS, Thomasma DC, Schon EA et al. Germ-line therapy to cure mitochondrial disease:-protocol and ethics of in vitro ovum nuclear transplantation. Cambridge Quart Hlthcare Ethics 1995; 4: 316-339.
36. Cohen J, Scott R, Schimmel R et al. Birth of an infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. Lancet 1997; 350: 186-187.